Edgar Vigil

Two inhibitors of yeast plasma membrane ATPase 1 (ScPma1p): toward the development of novel antifungal therapies

Jacob D. Durrant, Sabine Ottilie, Gregory M. Goldgof, 2018, Journal of Cheminformatics.

Rapid Chagas Disease Drug Target Discovery Using Directed Evolution in Drug-Sensitive Yeast.

Rommie E. Amaro, Jacob D Durrant, Rommie E Amaro, 2017, ACS chemical biology.

Comparative chemical genomics reveal that the spiroindolone antimalarial KAE609 (Cipargamin) is a P-type ATPase inhibitor

Rommie E. Amaro, Jacob D. Durrant, Elizabeth A. Winzeler, 2016, Scientific Reports.

Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond

Manuel Llinás, George Papadatos, Sundari Suresh, 2016, PLoS pathogens.